Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Tacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational study.

Authors
Type
Published Article
Journal
BMJ open gastroenterology
Publication Date
Volume
2
Issue
1
Identifiers
DOI: 10.1136/bmjgast-2014-000021
PMID: 26462273
Source
Medline
Keywords
License
Unknown

Abstract

TAC and IFX had similar effects on remission induction in patients with severely active UC. Sequential therapies could rescue patients with UC who failed initial treatment with TAC or IFX. In clinical practice, sequential therapies might be deliberately performed.

Statistics

Seen <100 times